Sinopharm Group Co. Ltd. announced that on 22 March 2019, due to work arrangement, Mr. Wang Qunbin tendered his resignation as a non-executive director of the Company, a member of the nomination committee of the Board, a member of the strategy and investment committee of the Board. On the same day, the Board resolved to propose to appoint Ms. Dai Kun as a non-executive director of the Company. In accordance with the articles of association of the Company, the proposed appointment of Ms. Dai Kun as non-executive director is subject to the approval by the shareholders at the general meeting of the Company. Mr. Deng Jindong, a non-executive director of the Company and Mr. Tan Wee Seng, an independent non-executive director of the Company, have been appointed as members of remuneration committee of the Board, both with effect from 22 March 2019.

The board proposed to distribute a final dividend of RMB 0.59 per share (tax inclusive) for the year ended 31 December 2018 (the "Final Dividend"), totaling approximately RMB 1,753,277,000. If the proposal of profit distribution is approved by shareholders at the 2018 annual general meeting to be held on 27 June 2019 (the "AGM"). The Final Dividend will be distributed to the shareholders whose names appear on the register of members of the Company on 9 July 2019 no later than 27 August 2019.